X0306 4 2017-02-21 0 0000883107 NANOPHASE TECHNOLOGIES Corp NANX 0001051331 MCCLUNG JAMES A 1319 MARQUETTE DRIVE ROMEOVILLE IL 60446 1 0 0 0 Common Stock 30071 I By Wife Common Stock 17582 D Stock Option (right to buy) 1.36 2012-01-31 2021-01-31 Common Stock 12000 12000 D Deferred Common Stock Common Stock 2250 21596 D Stock Option (right to buy) 0.30 2013-08-07 2022-08-07 Common Stock 12000 12000 D Stock Option (right to buy) 0.415 2014-02-14 2023-02-14 Common Stock 12000 12000 D Stock Option (right to buy) 0.52 2015-02-13 2024-02-13 Common Stock 12000 12000 D Stock Option (right to buy) 0.44 2016-02-18 2025-02-18 Common Stock 10800 10800 D Stock Option (right to buy) 0.42 2017-02-23 2026-02-23 Common Stock 9720 9720 D Stock Option (right to buy) 0.90 2016-11-17 2026-11-17 Common Stock 2250 2250 D Stock Option (right to buy) 1.05 2016-11-17 2026-11-17 Common Stock 2250 2250 D Stock Option (right to buy) 1.18 2016-11-17 2026-11-17 Common Stock 2250 2250 D Stock Option (right to buy) 0.84 2016-11-17 2026-11-17 Common Stock 2250 2250 D Stock Option (right to buy) 1.85 2016-11-17 2026-11-17 Common Stock 2250 2250 D Stock Option (right to buy) 1.10 2016-11-17 2026-11-17 Common Stock 2250 2250 D Stock Option (right to buy) 0.99 2016-11-17 2026-11-17 Common Stock 2250 2250 D Common Stock (right to buy) 0.68 2017-02-21 4 A 0 12000 0.68 A 2018-02-21 2027-02-21 Common Stock 12000 12000 D Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Each share of deferred common stock represents a right to receive one share of common stock. The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company. Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 21,596 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan. Beginning on this date, and subject to certain restrictions, the stock options vest in three equal annual installments. Beginning on this date, and subject to certain restrictions, options vest in three equal annual installments. The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,250 were issued with an exercise price of $0.90, 2,250 were issued with an exercise price of $1.05, 2,250 were issued with an exercise price of $1.18, 2,250 were issued with an exercise price of $0.84, 2,250 were issued with an exercise price of $1.85, 2,250 were issued with an exercise price of $1.10, and 2,250 were issued with an exercise price of $0.99. By Jess Jankowski under UPA for James A. McClung 2017-02-22